PRODH and cancer: We have previously described a sensitive albeit indirect measure of mitochondrial PRODH activity using isolated cancer cell mitochondria exposed ex vivo or in vivo to doses of either a reversible (L-THFA or S-5-oxo) or irreversible (N-PPG) PRODH inhibitor (Scott et al. 2019).